Introduction {#S0001}
============

Investigation of potential embolic sources is an important diagnostic step in treating patients with acute ischemic stroke or transient ischemic attack (TIA), especially when the mechanism is considered to be embolic. Cardiogenic embolism has been estimated to be the causative factor in 20-40% of all cases of stroke \[[@CIT0001]--[@CIT0003]\]. Atrial fibrillation (AF) is the most common cause of embolic sources from the heart, and AF-related strokes constitute about 60% of all cardioembolic strokes \[[@CIT0004]\]. Patients with stroke and AF frequently have concomitant potential cardiac sources of embolism and are at increased risk of recurrent embolism, despite anticoagulation \[[@CIT0005], [@CIT0006]\]. The detection of certain concomitant potential cardiac sources of embolism in patients with stroke and AF may thus help to identify a patient group with a high risk of recurrent stroke. Furthermore, preexisting atrial thrombus should be excluded before the cardioversion of atrial fibrillation or catheter ablation to avoid embolization.

Thromboembolism, usually originating from the left atrium (LA) and left atrial appendage (LAA), is a major complication of AF and may result in TIA and stroke \[[@CIT0007]\]. Accordingly, the 2007 Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society consensus statement recommends pre-procedural transesophageal echocardiography (TEE) in order to screen for the presence of thrombus, especially in patients with persistent AF at the time of ablation \[[@CIT0008]\]. Although TEE is still considered the gold standard to exclude LA/LAA thrombus, TEE requires special skills for proper performance and interpretation. Additionally, it is a relatively invasive test, usually performed with the patient under conscious sedation \[[@CIT0009], [@CIT0010]\].

Alternatively, a potentially non-invasive and efficacious method allowing identification of LA/LAA thrombus with reliability and accuracy comparable to TEE would be of significant clinical value. Recent advances in multi-detector spiral CT (MDCT), including improvements in temporal and spatial resolution, now allow accurate and consistent imaging of cardiac structure, including LA/LAA thrombus.

Over the last decade, mainly smaller studies have been performed among patients to determine the diagnostic value of MDCT for detecting LA/LAA thrombus, compared with TEE as the reference standard. However, sensitivity and specificity of MDCT in excluding LAA thrombus were varied in prior studies. However, the ability of MDCT to detect LA/LAA thrombus has never been systematically validated because of the small sample sizes. We therefore performed a meta-analysis to explore the potential diagnostic value of CT in detecting LA/LAA thrombus.

Material and methods {#S0002}
====================

Literature search {#S20003}
-----------------

This meta-analysis was performed in accordance with the Quality of Reporting of Meta-analysis (QUOROM) consensus guidelines and according to a protocol that prespecified outcomes, search strategies, inclusion criteria, and statistical analysis \[[@CIT0011]\]. We identified studies by a literature search of the PubMed, Medline, ISI Web of Knowledge and Cochrane Library databases up to June 2012 with the following key words: "left atrial thrombus", "left atrial appendage thrombus", "left atrial filling defects" or "left atrial appendage filling defects" plus "computed tomography". In addition, we reviewed the reference lists from all relevant articles to identify additional studies if necessary. All searches were conducted independently by 2 authors. The results were compared, and any questions or discrepancies were resolved through iteration and consensus.

Inclusion criteria for included studies {#S20004}
---------------------------------------

We included articles in any language that (i) compared MDCT with TEE as the reference standard; (ii) had a prospective design; (iii) included patients with suspected LA/LAA thrombus; (iv) involved multi-slice CT scanners (≥ 16 slice); (v) clearly stated the number of true positive, false positive, false negative, and true negative results for diagnosis of LA/LAA thrombus, or they could be calculated from the article; (vi) defined LA/LAA thrombus as an intracavitary contrast filling defect with attenuation values similar to non-enhanced tissue by MDCT; and (vii) defined LA/LAA thrombus as an intracavitary echogenic mass that could be distinguished from the surrounding tissue in more than one imaging by TEE.

Data extraction and quality assessment {#S20005}
--------------------------------------

Data were abstracted by use of specific data collection forms by two authors and checked for accuracy. We extracted data on study population characteristics, relevant technical information about the CT and TEE approach, and detailed reference standard specifications. We assessed methodological quality by the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool \[[@CIT0012]\] and individually tailored the guidelines for scoring each item in our review as suggested \[[@CIT0013]\].

Data synthesis and statistical analysis {#S20006}
---------------------------------------

We used meta-analysis software (MetaDisc, Version 1.4, Unit of Clinical Biostatistics, Ramón Y Cajal Hospital, Madrid, Spain; STATA, Version 11.0, StataCorp, College Station, TX, USA) for the analysis. The pooled indices of sensitivity and specificity with the corresponding 95% confidence intervals (CI) were calculated by using weighted averages according to the sample size of each study. The pooled estimates of positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio (DOR) were computed by the DerSimonian and Laird method based on a random-effects model \[[@CIT0014], [@CIT0015]\].

In addition, an assessment of diagnostic threshold variation among studies was undertaken using a summary receiver operating characteristic (SROC) curve. The SROC curve (and area under the curve) represents the overall performance of the test, and depicts the trade-off between sensitivity and specificity. A symmetric curve suggests that the variability in accuracy between studies is explained, in part, by differences in thresholds employed by the studies.

Heterogeneity in meta-analysis refers to the degree of variability in results across studies. Heterogeneity of results across trials was assessed with a standard χ^2^ test with significance set at *p* \< 0.10 and an *I* ^2^ statistic with significance set at *I* ^2^ \> 50%. A value of *p* \< 0.01 was considered statistically significant \[[@CIT0016]\]. Stratified (subgroup) analyses were used to identify study design and test-related factors responsible for heterogeneity in test accuracy.

Publication bias was assessed using several methods. Visual inspection of a funnel plot for vascular-related end-points was performed. A funnel plot provides a visual representation of each study included in the meta-analysis plotted by its effect size on the horizontal axis and variance on the vertical axis. When publication bias is not present, the funnel plot resembles an inverted funnel, with less precise studies having greater variance scattered at the bottom to either side of the more precise studies. If publication bias is present in a meta-analysis, the plot does not appear as an inverted, symmetrical funnel. Egger\'s weighted regression method was also used to assess publication bias (*p* \< 0.05 was considered representative of statistically significant publication bias) \[[@CIT0017]\].

Results {#S0007}
=======

Trial flow {#S20008}
----------

The primary search revealed 261 reports. At review, 239 reports were excluded after reading the abstract and a further 13 reports were excluded after reading the full report because they did not meet the inclusion criteria. We finally accepted 9 reports \[[@CIT0018]--[@CIT0026]\]. [Figure 1](#F0001){ref-type="fig"} shows the selection of studies for the study.

![Trial flow diagram of the literature search resulting in 9 included studies](AMS-8-19906-g001){#F0001}

Study characteristics {#S20009}
---------------------

From the literature search, 9 studies were accepted finally \[[@CIT0018]--[@CIT0026]\]. The study characteristics are shown in [Table II](#T0002){ref-type="table"}. The publication years spanned from 2007 to 2012. Patient enrolment in single studies ranged from 51 to 402 patients. The total number of patients was 1646. All of the included reports involved patients with AF or stroke who had high risk factors for thrombus formation. All of the reports described single-center prospective cohort studies. All of the reports used contrast-enhanced CT protocols to detect LA/LAA thrombus. In order to validate the CT results, all the included studies required patients to undergo TEE. Of all the included studies, LA/LAA thrombus was defined as an intracavitary contrast filling defect with attenuation values similar to non-enhanced tissue by MDCT and an intracavitary echogenic mass that could be distinguished from the surrounding tissue in more than one imaging by TEE. Of the 9 included studies, 6 used a 64-slice CT scanner \[[@CIT0018]--[@CIT0020], [@CIT0022]--[@CIT0024]\], 1 used a 128-slice CT scanner \[[@CIT0026]\], 2 involved 2 different types of scanners \[[@CIT0021], [@CIT0025]\], and 3 used a dual-source CT scanner \[[@CIT0019], [@CIT0020], [@CIT0026]\].

###### 

Criteria used to assess the methodological quality of included studies according to the QUADAS tool

  Quality item                                                                                                                                                              Positive score
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Was the spectrum of patients representative of the patients who will receive the test in practice?                                                                    Only patients suspected of stroke were included.
  2\. Were selection criteria clearly described?                                                                                                                            It was clear how patients were selected to undergo CT scan before and during or after IVUS exam.
  3\. Is the reference standard likely to enable correct classification of the target condition?                                                                            Transesophageal echocardiography was used as the reference standard.
  4\. Is the time period between the reference standard and index test short enough to be reasonably sure that the target condition did not change between the two tests?   Time period between CT and TEE was short enough.
  5\. Did the whole sample or a random selection of the sample receive verification with a reference standard?                                                              All patients or a random selection of the patients received verification with TEE.
  6\. Did patients receive the same reference standard regardless of the index test result?                                                                                 All patients received the same reference standard regardless of the index test result.
  7\. Was the reference standard independent of the index test?                                                                                                             The reference standard was independent of the index test.
  8\. Was the execution of the index test described in sufficient detail to permit replication of the test?                                                                 The CT scan protocol (scanner type, acquisition mode, reconstruction method, length of fasting before scanning, and interpreter(s)) was described.
  9\. Was the execution of the reference standard described in sufficient detail to permit its replication?                                                                 Sufficient details or citations were reported to permit replication of the TEE.
  10\. Were the index test results interpreted without knowledge of the results of the reference standard?                                                                  Interpretation of CT findings was performed without knowledge of IVUS findings.
  11\. Were the reference standard results interpreted without knowledge of the results of the index test?                                                                  Interpretation of the TEE results was performed without knowledge of the CT findings.
  12\. Were the same clinical data available when test results were interpreted as are available when the test is used in practice?                                         Clinical data, such as age, sex, and clinical symptoms, were available when CT results were interpreted.
  13\. Were uninterpretable and/or intermediate test results reported?                                                                                                      All CT results, including uninterpretable and/or intermediate results, were reported.
  14\. Were withdrawals from the study explained?                                                                                                                           It was clear what happened to all patients who withdrew from the study.

Methodological quality {#S20010}
----------------------

Findings from the QUADAS tool for quality assessment of diagnostic accuracy studies can be found in [Figure 2](#F0002){ref-type="fig"}. [Table I](#T0001){ref-type="table"} shows how the studies scored on each item. The quality and completeness of the reporting of studies were variable, and the studies were generally of high quality. All of the reports met the requirements for at least 8 of the items and in 8 of the 9 studies fulfilled more than 10 items of the 14-item QUADAS checklist. Ten of the QUADAS items were met by more than 75% of the studies.

![Methodological quality of included studies according to the QUADAS tool](AMS-8-19906-g002){#F0002}

###### 

Characteristics of included studies

  Study                               Country       Publication year   Number of patients   Mean age \[years\]   Men \[%\]   Disease status   TEE type    CT type-slice
  ----------------------------------- ------------- ------------------ -------------------- -------------------- ----------- ---------------- ----------- ------------------
  Dorenkamp *et al*. \[[@CIT0018]\]   Germany       2011               329                  62                   65          AF               5 MHz       64 s
  Kapa *et al*. \[[@CIT0019]\]        USA           2010               255                  58                   78          AF               3.5-7 MHz   Dual-source64 s
  Hur *et al*. \[[@CIT0020]\]         South Korea   2012               63                   64                   78          AF               5 MHz       Dual-source64 s
  Kim *et al*. \[[@CIT0021]\]         New York      2007               223                  57                   82          AF               5-7 MHz     16 and 64 s
  Martinez *et al*. \[[@CIT0022]\]    USA           2009               402                  56                   76          AF               3.5-7 MHz   64 s
  Singh *et al*. \[[@CIT0023]\]       USA           2009               51                   64                   73          AF               7 MHz       64 s
  Tang *et al*. \[[@CIT0024]\]        China         2008               170                  56                   72          AF               5 MHz       64 s
  Sawit *et al*. \[[@CIT0025]\]       New York      2012               70                   58                   73          AF               NA          64, 128and 256 s
  Hur *et al*. \[[@CIT0026]\]         South Korea   2011               83                   63                   67          Recent stroke    5-7 MHz     Dual-source128 s

NA -- data not available, AF -- atrial fibrillation, TEE -- transesophageal echocardiography

Quantitative data synthesis {#S20011}
---------------------------

True-positive (TP), false-negative (FN), false-positive (FP) and true-negative (TN) results for included reports are shown in [Table III](#T0003){ref-type="table"}. Among the 9 reports providing data on the diagnostic accuracy data of CT in detecting LA/LAA thrombus, the pooled sensitivity was 81% (95% CI: 70-90%) and the pooled specificity was 90% (95% CI: 88-91%) ([Figure 3](#F0003){ref-type="fig"}). To assess the impact of diagnostic threshold variation between studies, a symmetrical SROC curve was fitted ([Figure 4](#F0004){ref-type="fig"}). The SROC curve displays a ROC-type trade-off between sensitivity and specificity. The area under the curve (± SE) was 0.93 (±0.02), indicating very good diagnostic accuracy.

![Forest plot of pooled sensitivity and specificity of CT in diagnosis of LA/LAA thrombus](AMS-8-19906-g003){#F0003}

![SROC for CT in diagnosis of LA/LAA thrombus\
SROC -- summary receiver operating characteristic\
AUC -- area under the curve](AMS-8-19906-g004){#F0004}

###### 

Study results

  Study                               *N*   TP   FP   FN   TN    Sensitivity (95% CI)   Specificity (95% CI)
  ----------------------------------- ----- ---- ---- ---- ----- ---------------------- ----------------------
  Dorenkamp *et al*. \[[@CIT0018]\]   329   2    8    5    314   0.29 (0.04-0.71)       0.98 (0.95-0.99)
  Kapa *et al*. \[[@CIT0019]\]        255   4    29   0    222   1.00 (0.40-1.00)       0.88 (0.84-0.92)
  Hur *et al*. \[[@CIT0020]\]         63    13   18   0    32    1.00 (0.75-1.00)       0.64 (0.49-0.77)
  Kim *et al*. \[[@CIT0021]\]         223   3    42   0    178   1.00 0.29-1.00)        0.81 (0.75-0.86)
  Martinez *et al*. \[[@CIT0022]\]    402   9    31   0    362   1.00 (0.66-1.00)       0.92 (0.89-0.95)
  Singh *et al*. \[[@CIT0023]\]       51    2    2    0    47    1.00 (0.16-1.00)       0.96 (0.86-1.00)
  Tang *et al*. \[[@CIT0024]\]        170   4    10   7    149   0.36 (0.11-0.69)       0.94 (0.89-0.97)
  Sawit *et al*. \[[@CIT0025]\]       70    2    11   0    57    1.00 (0.16-1.00)       0.84 (0.73-0.92)
  Hur *et al*. \[[@CIT0026]\]         83    13   13   0    57    1.00 (0.75-1.00)       0.81 (0.70-0.90)

N -- number of patients, FN -- false negative, FP -- false positive, TN -- true negative, TP -- true positive, CI -- confidence interval

To determine the implications of our results for clinical use, we calculated the probability of CT detecting LA/LAA thrombus. [Table IV](#T0004){ref-type="table"} shows the likelihood ratio profile of CT (positive likelihood ratio = 6.24; negative likelihood ratio = 0.22) primarily as a tool for ruling out thrombus.

###### 

Stratified analysis for the evaluation of heterogeneity in studies

  Group or subgroup           Pooled sensitivity (95% CI),%   Pooled specificity (95% CI),%   Positive likelihood ratio (95% CI)   Negative likelihood ratio (95% CI)   Pooled diagnosticodds ratio (95% CI)
  --------------------------- ------------------------------- ------------------------------- ------------------------------------ ------------------------------------ --------------------------------------
  All reports                 0.81 (0.70-0.90)                0.90 (0.88-0.91)                6.24 (4.05-9.63)                     0.22 (0.08-0.59)                     26.44 (11.97-58.41)
  CT type:                                                                                                                                                              
   Dual-source                1.00 (0.88-1.00)                0.84 (0.80-0.87)                4.65 (2.39-9.07)                     0.07 (0.01-0.31)                     71.83 (13.44-383.95)
   Others                     0.65 (0.46-0.80)                0.91 (0.90-0.93)                7.55 (4.63-12.31)                    0.41 (0.18-0.94)                     21.53 (8.07-57.41)
  Study quality:                                                                                                                                                        
   QUADAS item \> 10          0.74 (0.59-0.86)                0.92 (0.90-0.94)                5.54 (3.03-10.13)                    0.34 (0.12-0.99)                     22.18 (7.32-67.20)
   QUADAS item ≤ 10           1.00 (0.81-1.00)                0.88 (0.86-0.90)                7.00 (4.35-11.26)                    0.12 (0.03-0.44)                     60.04 (13.59-265.19)
  Prospective study design:                                                                                                                                             
   Yes                        0.33 (0.13-0.59)                0.96 (0.94-0.98)                7.33 (3.30-16.27)                    0.70 (0.51-0.97)                     10.72 (3.59-32.01)
   No or unclear              1.00 (0.92-1.00)                0.87 (0.85-0.89)                6.04 (3.69-9.90)                     0.10 (0.04-0.27)                     67.50 (21.85-208.48)

CI -- confidence interval, QUADAS -- Quality Assessment of Diagnostic Accuracy Studies

To assess possible explanations for the heterogeneity, we performed stratified analysis to identify sources of heterogeneity among included studies. [Table IV](#T0004){ref-type="table"} presents three factors that were found to be most strongly associated with the observed heterogeneity. The estimated DOR was nearly 6.3 times lower with a prospective study design than no or unclear study design. Studies with CT types that used a dual-source CT scanner produced diagnostic odds ratio estimates 2.3 times higher than studies that used other MDCT. In addition to the above two factors, quality of the study also affected the results. However, even after stratifying by study design and target sequence, considerable unexplained heterogeneity persisted in all the summary measures. The shape of the SROC curve suggested that variability in diagnostic thresholds (cut-points) across studies could partly explain the heterogeneity.

The evaluation of publication bias showed that the Egger test was significant (*p* = 0.003). The funnel plot also showed marked asymmetry, with studies missing from the left, suggesting a publication bias ([Figure 5](#F0005){ref-type="fig"}).

![Funnel plot of this meta-analysis](AMS-8-19906-g005){#F0005}

Discussion {#S0012}
==========

Atrial fibrillation is the most common cause of embolic sources from the heart, and AF-related strokes constitute about 60% of all cardioembolic strokes \[[@CIT0004]\]. Prevalence of AF is a major risk factor not only for stroke, but also for other cardiovascular events, such as cardiovascular death, unstable angina and myocardial infarction. One report has shown that the annual incidence of nonfatal stroke and unstable angina was higher, and cardiovascular death was more than double, in AF versus non-AF patients. Although numerically higher with AF, there was little difference in the rate of nonfatal myocardial infarction between AF and non-AF patients \[[@CIT0027]\]. There were notable differences in the baseline characteristics and risk factor profile of patients with AF compared with non-AF patients, with older age, higher prevalence of hypertension, and a larger waist circumference. These differences may contribute to cardiovascular events for patients with AF \[[@CIT0027]\].

Thrombi of the LA and LAA are common sources of stroke, and because LA and LAA thrombi are treatable sources of embolism, the detection of thrombi may significantly affect patient management. Currently, TEE is considered the reference standard for the detection of intracardiac thrombus. The main advantages of TEE include high temporal and spatial resolution, as well as the lack of radiation and contrast exposure. However, TEE requires special skills for proper performance and interpretation. Additionally, it is a semi-invasive test, usually performed under conscious sedation \[[@CIT0009], [@CIT0010], [@CIT0028]\]. Multi-detector spiral CT allows visualization of the entire LA, including the LAA. In most cases, anatomic rendering of the left atrium and pulmonary veins using CT is performed in addition to TEE to exclude the presence of thrombus in the LAA. Contrast enhanced cardiac MDCT provides high-resolution volumetric data sets of the heart and adjacent anatomical structures. It would be a clinically useful setting to rule out LA/LAA thrombus with the identical MDCT data set, obviating the need for pre-procedural TEE.

Alternative diagnostic approaches for the visualization of LA/LAA thrombus must prove their accuracy, reliability, and prognostic value before they can be recommended for clinical practice. We performed a meta-analysis of the diagnostic performance of CT as a potential noninvasive method for detecting LA/LAA thrombus compared with TEE as the reference standard. [Table III](#T0003){ref-type="table"} displays the sensitivity and specificity estimates from each of the 9 studies in detecting LA/LAA thrombus. Both sensitivity (range: 0.29-1.0) and specificity (range: 0.64-0.98) estimates were highly variable. Among these reports, two prospective reports have very low sensitivities (29% and 36%, respectively) \[[@CIT0018], [@CIT0024]\] and others have 100% sensitivity. Differences in sensitivity and specificity between the studies may be presumed to be partially attributable to: (i) a relatively low rate of thrombus occurrence in the studied patient populations; (ii) contrast bolus techniques and (iii) different experience levels of the interpreting physicians. Despite the high heterogeneity, we observed a good weighted sensitivity of 81% and specificity of 90% for CT in the detection of LA/LAA thrombus as compared with TEE. The area under the SROC curve (± SE) was 0.93 (± 0.02), indicating very good diagnostic accuracy.

Of note, we found significant heterogeneity in results among the included studies. Thus, our results should be interpreted cautiously, although our use of a random-effects model meta-analysis should correct for this issue at least in part. Use of stratified analysis may explain some of the sources of heterogeneity. Computed tomography type, study quality and prospective study design may be sources of the heterogeneity. Funnel plot of included studies showed a significant publication bias as well.

Intracavitary LA/LAA thrombi present as filling defects on MDCT. However, such defects may also result from inadequate mixing of contrast agent and blood and may even give the false-positive appearance of thrombus. Conditions associated with altered atrial blood-flow patterns, in particular AF, may favor the occurrence of filling artifacts that are incorrectly interpreted as thrombus \[[@CIT0023], [@CIT0024]\].

Our meta-analysis contains some limitations. First, most of the included studies performed the 2 examinations within a 3-day period but not on the same day. Thrombus could have formed or been lysed in the time between the TEE and CT examinations. Second, differences in the experience levels of the interpreting physicians could contribute to differences in results between studies. Third, only 2 of the studies had a prospective design; one limitation is the reliance on chart review for data collection. Fourth, because meta-analysis combines or integrates the results of several independent studies, the quality and reliability depend on the quality of included studies. We used the QUADAS tool for assessing methodological quality of individual studies as they were reported. Though 8 of the 9 studies fulfilled more than 10 items of the 14-item QUADAS checklist, the included studies we reviewed scored poorly on selection criteria, relevant clinical information and reference standard execution. The high number of items that scored "unclear" shows the need for further improvement in this regard. Finally, a common limitation in undertaking meta-analyses is the issue of publication bias, in which clinical trials with statistically significant results are published and those with undesirable results frequently are not \[[@CIT0029]\]. The funnel plot of included studies suggests the presence of publication bias, which may have led to an overestimation of the true diagnostic performance. Other very different mechanisms can also lead to asymmetry in funnel plots, including true heterogeneity, data irregularities, artifacts and chance.

Transesophageal echocardiography is not only the imaging method of choice for the detection of LAA thrombus, but is also able to detect cardioembolic sources such as patent foramen ovale, valvular vegetations, and mobile thrombi in the aorta. Transesophageal echocardiography is also a valuable tool to image thoracic aortic atheroma associated with the prevalence of high-risk coronary anatomy \[[@CIT0030]\]. In addition, in contrast to CT, TEE can be performed in patients with renal dysfunction or an allergy to contrast media. However, TEE is a time-consuming, invasive, and uncomfortable procedure. Furthermore, thrombus evaluation involves individual judgment that is reader dependent. Therefore, in clinical practice, a less invasive modality that is capable of assessing intracardiac thrombus in the setting of embolic stroke is desirable. With ongoing technical developments, CT might have more potential in detecting LA/LAA thrombus. Additional detector rows and improvements in temporal resolution will advance CT technology. Thus, we believe that CT can be used as an alternative modality for detecting thrombus in selected patients with stroke or AF, because it has high diagnostic accuracy for the detection of intracardiac thrombus, and is a noninvasive and reproducible modality. In addition, coronary artery calcium measurement, determined with CT, is a powerful predictor of future cardiovascular risk \[[@CIT0031]\].

Finally, we note that, even though CT is a noninvasive method compared to TEE, the radiation exposure is a disadvantage of CT. One report has mentioned that CT examinations may be associated with increased risk of future fatal cancer. This risk varies markedly and is considerably greater for women, younger patients, and for combined cardiac and aortic scans \[[@CIT0032]\]. Hence further development of a system with a lower radiation exposure dose for use in clinical radiology will be necessary.

In conclusion, CT should be considered the foremost noninvasive alternative to TEE for detecting LA/LAA thrombus. Randomized studies at the patient level are needed to address the potential use of CT in detecting LA/LAA thrombus.
